Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,824.04
(
0.10%
)
News Focus
News Focus
Post# of 785
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

MomsSpaghetti

Send PM Follow Ignore
Followers 84
Posts 5918
Boards Moderated 5
Alias Born 08/21/2015

MomsSpaghetti

Re: IHuser post# 618

Thursday, 10/02/2025 9:02:57 PM

Thursday, October 02, 2025 9:02:57 PM

Post# of 785
Xanax for anxiety will be overshadowed by the next class of drugs in the psychedelic market. I look for AZN to buyout MNMD and or ATAI in the very near future. Both company hot on the tails of these big players with multiple phase 3 trials underway with LSD and DMT for GAD, MDD and TRD. LSD already has FDA breakthrough status designation. Big things are coming.
Bullish
Bullish
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AZN News
More AZN News